Sound familiar? OCT 28, 2020 Dr. Paul Marik: I
Post# of 148112
(Total Views: 644)
Posted On: 10/29/2020 7:51:08 PM
Sound familiar?
OCT 28, 2020
Dr. Paul Marik: Ivermectin Works and Should be Accepted for Large Observational Studies
"The FDA approved drug Ivermectin was first demonstrated to inhibit SARS-CoV-2 by University of Monash, causing a 5000-fold reduction in viral RNA at 48 hours.
"..SARS-CoV-2 proteins..need to bind..to importin proteins (alpha and beta)..allowing the SARS-CoV-2 proteins into the nucleus...“they cause havoc, cell arrest, they interfere with DNA transcription and promote viral replication.”
"Ivermectin binds to the importin complex and prevents SARS-CoV-2 proteins from binding to this importin mechanisms; therefore, the SARS-CoV-2 proteins cannot penetrate the nuclear core.
"..professor and doctor goes on to review four clinical studies..with mortality as an endpoint. He argues that the results indicate a “highly significant reduction in mortality.”
"Although the National Institute of Health (NIH) Guidelines declares Ivermectin should only be used in clinical trials for COVID-19, they do now include the anti-parasite drug in the guidelines which wasn’t the case months ago.
"A growing tension mounts between research and regulatory authorities on the one side, and a rising number of independent-minded researchers and clinicians on the other side declaring sufficient data is in place for public funding in support of this economical and widely available generic drug.
"..appear to be a split in India between the national authorities and at least some state’s treatment guidelines that accept Ivermectin
"He notes Remdesivir doesn’t reduce mortality. Remdesivir is the only drug approved by the U.S. Food and Drug Administration (FDA) for use against COVID-19.
https://www.trialsitenews.com/dr-paul-marik-i...bservation
OCT 28, 2020
Dr. Paul Marik: Ivermectin Works and Should be Accepted for Large Observational Studies
"The FDA approved drug Ivermectin was first demonstrated to inhibit SARS-CoV-2 by University of Monash, causing a 5000-fold reduction in viral RNA at 48 hours.
"..SARS-CoV-2 proteins..need to bind..to importin proteins (alpha and beta)..allowing the SARS-CoV-2 proteins into the nucleus...“they cause havoc, cell arrest, they interfere with DNA transcription and promote viral replication.”
"Ivermectin binds to the importin complex and prevents SARS-CoV-2 proteins from binding to this importin mechanisms; therefore, the SARS-CoV-2 proteins cannot penetrate the nuclear core.
"..professor and doctor goes on to review four clinical studies..with mortality as an endpoint. He argues that the results indicate a “highly significant reduction in mortality.”
"Although the National Institute of Health (NIH) Guidelines declares Ivermectin should only be used in clinical trials for COVID-19, they do now include the anti-parasite drug in the guidelines which wasn’t the case months ago.
"A growing tension mounts between research and regulatory authorities on the one side, and a rising number of independent-minded researchers and clinicians on the other side declaring sufficient data is in place for public funding in support of this economical and widely available generic drug.
"..appear to be a split in India between the national authorities and at least some state’s treatment guidelines that accept Ivermectin
"He notes Remdesivir doesn’t reduce mortality. Remdesivir is the only drug approved by the U.S. Food and Drug Administration (FDA) for use against COVID-19.
https://www.trialsitenews.com/dr-paul-marik-i...bservation
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼